NCT01094288 2019-02-15A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel RegimenTakedaPhase 1 Completed41 enrolled 31 charts